Liberty Energy Inc. Class A common stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Liberty Energy Inc. Class A common stock trades at $17.99 (market cap $3.12B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Liberty Energy Inc. Class A common stock is the larger of the two by market cap, and Liberty Energy Inc. Class A common stock pays a 1.88% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Liberty Energy Inc. Class A common stock for 6 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| LBRT | VIR | |
|---|---|---|
Market Cap | $3.12B | $1.80B |
Volume | 2,205,743 | 1,782,836 |
Sector | Energy | Health |
52-Week High | $33.93 | $11.78 |
52-Week Low | $11.94 | $5.12 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $4.18B | $1.36B |
Dividend Yield | 1.88% | — |
Signals from Pluang's Aura AI — not financial advice
Liberty Energy (LBRT) trades at $19.11, up 0.68% today, with a bearish technical signal but strong analyst support. The stock has beaten earnings estimates for three consecutive quarters, with Q3 2026 results expected soon. Revenue reached $4.01B in 2025, though net margins are thin at 2.92%. Valuation metrics like P/E of 25.82 and P/S of 0.75 suggest mixed attractiveness relative to profitability.
Outlook is cautiously optimistic given earnings momentum and a $28.38 consensus price target, but risks include margin pressure from rising costs and execution challenges in expanding into data center power. The stock's proximity to its 52-week low of $19.00 highlights downside vulnerability if Q3 results disappoint.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Liberty Energy provides completion services and technologies for onshore oil, natural gas, and geothermal producers in North America. It also offers distributed power and energy-storage solutions through Liberty Power Innovations.
Read more on LBRT →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →